Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
Women with BRCA gene mutations often choose preventive measures, study finds
FRIDAY, Aug. 7 (HealthDay News) -- Many women with a high risk of breast or ovarian
cancer have surgery to remove their breasts or ovaries in order to reduce the likelihood of developing cancer, English resear...
'Suicide' Genes Help Slow Ovarian Tumor Growth in Mice
Treatment could be tested in women within 18 to 24 months, expert suggests
THURSDAY, July 30 (HealthDay News) -- Treatment with "suicide" genes slowed ovarian
tumor growth in mice and may one day offer a way to treat late-stage ovarian
cancer in women, U.S. scientists say.
Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth
Potential late-stage ovarian
cancer therapy; currently none available; Diphtheria-encoding genes delivered to tumor site by nanoparticles; Laboratory research; possible human trials about 18 months away
Philadelphia (Vocus) July 29, 2009 -- Nanoparticle delivery of diph...
JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial antitumor activity in ovarian
cancer cell lines and in mice, according to a study published online July 29 in the Journal of the National Cancer Institute .
The agent, known as an im...
New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer
CHICAGO, July 22 /PRNewswire-FirstCall/ -- Ovarian
malignancies are a leading cause of cancer death in women because they are usually detected in the late stages when the disease is incurable. Encouraging new research presented by Abbott today at the American Association for Clinical Ch...
Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
HORSHAM, Pa., July 15 /PRNewswire/ -- Based on the data presented today, the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended that the combination of trabectedin when administered with DOXIL(R) (doxorubicin HCI liposome injection) did not provide a...
Hormone Therapy Increases Odds of Ovarian Cancer
But risk remains low and decreases two years after stopping, study finds,,
TUESDAY, July 14 (HealthDay News) -- Women who take hormone replacement therapy or have taken it in the recent past have a higher risk of developing ovarian
cancer, suggests new research.
In a large Danish s...
The Perfect Pair: Kelly Ripa and Mark Consuelos Team Up to Fight Ovarian Cancer
WEST CHESTER, Pa., July 13 /PRNewswire/ -- From A-list parties and red carpet events to school trips and PTA meetings, Kelly Ripa and Mark Consuelos are certainly one of the busiest celebrity couples. Yet, even with three children and two successful careers, the dynamic duo are about t...
Acupuncture, Exercise May Ease Polycystic Ovarian Syndrome
Common condition can cause menstrual woes, infertility, researchers note
THURSDAY, July 9 (HealthDay News) -- Acupuncture and exercise may bring some relief to the one in 10 women of childbearing age who suffer from a common endocrine disease called polycystic ovarian
syndrome (PCOS). ...
Early Menstruation Lowers Odds of Surviving Ovarian Cancer
Patients who had first period before age 12 are at increased risk of death, study shows
THURSDAY, July 9 (HealthDay News) -- Among women with ovarian
cancer, those who had their first menstrual period before the age of 12 and who had the most menstrual cycles over a lifetime are more l...
Polycystic ovarian syndrome: New light on its causes and its effect on brothers
Amsterdam, The Netherlands: Researchers have found evidence that chronic disease in either a mother or father can create unfavourable conditions in the womb that are associated with the development of polycystic ovarian
syndrome (PCOS) in daughters. In another study, researchers found that brother...
Reduced ovarian reserve associated with increased risk of trisomic pregnancy
Amsterdam, The Netherlands: Women who have a diminished number of eggs in their ovaries, either because they are older or for some other reason such as ovarian
surgery, may be more at risk of a trisomic pregnancy than women with an ovarian
reserve within the normal, fertile range.
Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
ProLindac Showing High DACH Platinum Activity; Drug Well Tolerated With No Signs of Acute Neurotoxicity
DALLAS, June 1 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC . ( http://www.accesspharma.com ) (OTC Bulletin Board: ACCP), provided an update today on the progress ...
Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...
New Insights, Inroads Against Breast, Ovarian Cancers
cancer test loses luster, but new breast tumor treatments called 'exciting'
SUNDAY, May 31 (HealthDay News) -- "It's nice to be here. It's nice to be anywhere," singer and actress Olivia Newton-John, a self-described 17-year breast cancer "thriver," told reporter...
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
-- Conference Call Scheduled for Monday June 1 at 1:00 PM ET to Discuss ASCO Data Presentations --
SOUTH SAN FRANCISCO, Calif., May 26 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of ne...
The Diagnosis Every Woman Dreads - Ovarian Cancer
SARASOTA, Fla., May 21 /PRNewswire/ -- As a health care practitioner, Trina Hammack knew the statistics. So when she was diagnosed with ovarian
cancer, she knew her prognosis was bleak. Fortunately, Hammack was familiar with a clinic in Mexico offering effective new treatments for ovarian
Chemo Combo Shows Promise Against Ovarian Cancer
Lab-based study focused on certain types of malignancies
SUNDAY, April 19 (HealthDay News) -- Adding the drug dasatinib to a standard, two-drug chemotherapy regimen for treating ovarian
cancer boosted the effectiveness of the drugs in laboratory tests, new research shows.
Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
DURHAM, N.C. The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian
cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center.
Catching Ovarian Cancer Early May Miss Aggressive Tumors
The finding casts the usefulness of screening into doubt, scientists say
TUESDAY, March 24 (HealthDay News) -- Early-stage ovarian
cancers may be slower growing and less likely to spread than the more aggressive forms typically found in advanced stages of the disease, researchers repor...
Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
EXTON, Pa., March 23 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that the U.S. Food and Drug Administration (FDA) has agreed to and approved the design of a single, pivotal, Phase III clinical trial evaluating farletuzumab (also known a...
Combo Screening Doesn't Spot Early Ovarian Cancer
Even finding it early may not save lives, researchers say,,,,
FRIDAY, March 20 (HealthDay News) -- A screening regimen that combines ultrasound and a blood test to detect CA125, a marker for ovarian
cancer, fails to discover the cancer in its early stages and often results in unnecessa...
Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer
New updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Ovarian
Cancer were presented at the NCCN 14th Annual Conference on March 14. Notable additions to the NCCN Guidelines are a section on managing allergic reactions to chemotherapy agents and new agents for recurr...
Combo of Tests Might Spot Ovarian Cancer Early
Preliminary findings offer hope against a silent killer,,
TUESDAY, March 10 (HealthDay News) -- Used together, a blood test and an ultrasound scan may be effective in detecting ovarian
cancer in its early and more curable stages, British researchers report.
The two-step detection m...
Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Data Presented at the Society of Gynecologic Oncologists' 40th Annual Meeting on Women's Cancer Proves Superiority of HE4, CA125 and ROMA(TM) Over Existing Tools
MALVERN, Pa., Feb. 11 /PRNewswire/ -- New data presented on Saturday during the plenary session at the Society of Gynecologic Oncol...
Fertility Drugs Do Not Increase Ovarian Cancer Risk
Women who have multiple treatments face little danger, Danish study says
FRIDAY, Feb. 6 (HealthDay News) -- Women who take fertility drugs do not have an increased risk of developing ovarian
cancer, according to a large study by Danish researchers.
There's been ongoing debate about...
Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
SAN ANTONIO - Researchers from The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis, or blood vessel formation, and vascular endothelial growth factor expression are associated with poor survival in women with sex cord-stromal ovarian
tumors. This data was pr...
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers
Test may help physicians identify effective treatment earlier
MALVERN, Pa. and Abbott Park, Ill., Jan. 27 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to develop a new ovarian
cancer test for use on Abbott's automated ARCHITECT(R) diagnostic analyze...
The 2009 Damon Runyon-Rachleff Innovation Award Granted for Pioneering Ideas for Early Detection of Ovarian and Lung Cancers, Bone Marrow Transplant Safety, and Discovery of New Genetic Markers for Cancer
NEW YORK and PALO ALTO, Calif., Jan. 22 /PRNewswire-USNewswire/ -- The Damon Runyon Cancer Research Foundation announced today that three novel approaches to fighting cancer have won 2009 Damon Runyon-Rachleff Innovation Awards. The prize of $450,000 over three years is awarded each year to three...
Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer
Yet another reason to use a treadmill desk to prevent obesity: ovarian
Phoenix, AZ (PRWEB) January 8, 2009 -- Yet another alarm bell has been set off by the medical community warning of America's rising obesity rates and the corresponding relation to disease. ...
Obesity Linked to Ovarian Cancer
Excess estrogen may contribute to malignancy, study suggests
MONDAY, Jan. 5 (HealthDay News) -- Obese postmenopausal women who have never used hormone replacement therapy may face an increased risk of ovarian
cancer, compared to normal-weight women, a new study suggests.
Study links obesity to elevated risk of ovarian cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian
cancer compared with women of normal weight. Published in the February 15, 2009 issue of CANCER , a peer-reviewed journal of the Americ...
Minimizing obesity's impact on ovarian cancer survival
BIRMINGHAM, Ala. Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian
cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian
cancer survival rates are the same for obes...
Low Levels of 2 Enzymes in Ovarian Cancer Cells Shortened Survival
Finding could lead to new treatments for this deadly disease, researchers say
WEDNESDAY, Dec. 17 (HealthDay News) -- Women with ovarian
cancer who had low levels of either of two enzymes associated with their tumors tended to die much sooner than women who had higher levels of one of t...
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Fujirebio Diagnostics' HE4 Test will be Available Through Roche Diagnostics' Automated Immunoassay Analyzers
MALVERN, Pa. and Basel, SwitzerlandDec. 16 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Roche Diagnostics announced today a worldwide license and supply agreement for the HE4 ov...
Stopping ovarian cancer by blocking proteins coded by notorious gene Ovarian
cancer cells are "addicted" to a family of proteins produced by the notorious oncogene, MYC, and blocking these Myc proteins halts cell proliferation in the deadliest cancer of the female reproductive system, according to a presentation by University of California, Berkeley scientists at t...
Blocking Oncogene Can Stop Spread of Ovarian Cancer
Lab study showed it had effect on 60% Of malignant cells
MONDAY, Dec. 15 (HealthDay News) -- Blocking proteins produced by the oncogene MYC can stop the spread of ovarian
cancer, researchers say.
An oncogene is a gene that has the potential to help cause cancer.
In up to 60 perce...
Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
(TORONTO: December 4, 2008) - An Ontario study of 491 women with invasive ovarian
cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.
Dr. Kelly Metcalfe, an ...
International study supports new standard of treatment for women with advanced ovarian cancer
Louisville, Ky. Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian
cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. The study, presented ...
Study unmasks how ovarian tumors evade immune system
Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian
tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked. Ovarian
cancer is considered to be one of the most aggressive malignancies, ki...